lysine has been researched along with celastrol in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M | 1 |
| Duan, WJ; He, RR; Kurihara, H; Li, YF; Liang, L; Luo, X; Ouyang, SH; Sun, WY; Wang, X; Wu, YP; Yan, CY | 1 |
2 other study(ies) available for lysine and celastrol
| Article | Year |
|---|---|
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries | 2023 |
Celastrol ameliorates Propionibacterium acnes/LPS-induced liver damage and MSU-induced gouty arthritis via inhibiting K63 deubiquitination of NLRP3.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Gouty; HEK293 Cells; Humans; Inflammasomes; Lipopolysaccharides; Liver; Lysine; Macrophages; Male; Mice, Inbred C57BL; Mice, Mutant Strains; NLR Family, Pyrin Domain-Containing 3 Protein; Pentacyclic Triterpenes; Propionibacterium acnes; THP-1 Cells; Triterpenes; Ubiquitination; Uric Acid | 2021 |